Sanofi turns infectious R&D over to Evotec

Sanofi (Euronext:SAN; NYSE:SNY) and Evotec AG (Xetra:EVT) partnered on Thursday to develop an infectious disease pipeline led by Evotec, seeded with more than 10 undisclosed early

Read the full 268 word article

User Sign In